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Abstract
Background: The Musculoskeletal Health Questionnaire (MSK-HQ) has been developed to measure musculoskeletal
health status across musculoskeletal conditions and settings. However, the MSK-HQ needs to be further evaluated
across settings and different languages.
Objective: The objective of the study was to evaluate and compare measurement properties of the MSK-HQ across
Danish (DK) and English (UK) cohorts of patients from primary care physiotherapy services with musculoskeletal
pain.
Methods: MSK-HQ was translated into Danish according to international guidelines. Measurement invariance was
assessed by differential item functioning (DIF) analyses. Test-retest reliability, measurement error, responsiveness and
minimal clinically important change (MCIC) were evaluated and compared between DK (n = 153) and UK (n = 166)
cohorts.
Results: The Danish version demonstrated acceptable face and construct validity. Out of the 14 MSK-HQ items,
three items showed DIF for language (pain/stiffness at night, understanding condition and confidence in managing
symptoms) and three items showed DIF for pain location (walking, washing/dressing and physical activity levels).
Intraclass Correlation Coefficients for test-retest were 0.86 (95% CI 0.81 to 0.91) for DK cohort and 0.77 (95% CI 0.49
to 0.90) for the UK cohort. The systematic measurement error was 1.6 and 3.9 points for the DK and UK cohorts
respectively, with random measurement error being 8.6 and 9.9 points. Receiver operating characteristic (ROC)
curves of the change scores against patients’ own judgment at 12 weeks exceeded 0.70 in both cohorts. Absolute
and relative MCIC estimates were 8–10 points and 26% for the DK cohort and 6–8 points and 29% for the UK
cohort.
Conclusions: The measurement properties of MSK-HQ were acceptable across countries, but seem more suited for
group than individual level evaluation. Researchers and clinicians should be aware that some discrepancy exits and
should take the observed measurement error into account when evaluating change in scores over time.
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Background
Pain in muscles and joints is one of the Western World’s
chief public health concerns and a leading cause of re-
duced functional and working capacity [1]. In order to
develop effective treatments, and to evaluate their ef-
fects, reliable and valid measurement tools are essential.
The health-related consequences of musculoskeletal dis-
orders, such as back and knee pain, can rarely be identi-
fied or measured using diagnostic imaging or other
objective measurement methods [2–5]. Therefore, pa-
tient reported outcomes measures (PROMs) are increas-
ingly used to support the assessment, treatment and
monitoring of persons with musculoskeletal disorders
[6]. PROMs reveal a person’s perceived symptoms, func-
tional ability and quality of life, and are typically admin-
istered via questionnaire. A wide range of questionnaires
for musculoskeletal disorders have been developed.
However, these questionnaires are typically limited to
specific parts of the body, e.g. pain in the shoulder and
arm [7], neck and back [8, 9], hip and knee [10]. Al-
though, region-specific questionnaires in specific patient
population and clinical trials serves its purpose well, they
can often be difficult to administrate for health care pro-
fessionals (e.g. general practitioners and physiothera-
pists) in primary care, who see patients with diverse
musculoskeletal disorders, often presenting with concur-
rent pain from several locations [11]. Although, more
general musculoskeletal questionnaires exist [12, 13],
these are relatively comprehensive in length and there-
fore less suited to evaluate changes over time, because of
the burden of administration and patient completion at
multiple time points. In addition, some only cover a
small number of health-related domains (e.g. pain and
function) [13], and thereby may not be sensitive to the
multidimensionality of treatment targets inherent in
managing musculoskeletal disorders.
As a consequence, Versus Arthritis (https://www.ver-
susarthritis.org) funded collaboration between the uni-
versities of Oxford and Keele to develop the
Musculoskeletal Health Questionnaire (MSK-HQ) in
2012 [14]. The MSK-HQ aims to capture patient and
clinician prioritised key outcomes across a range of mus-
culoskeletal conditions. The instrument consists of 14
items and covers a number of health-related domains,
including symptoms, physical functioning, daily activities
and work, physical well-being, confidence to manage
symptoms, condition understanding and social activities.
Each item on the MSK-HQ is answered on a 5-point
verbal rating scale (responses coded from ‘not at all’=4
to ‘extremely’ = 0, except for items 12 ‘understanding
condition’ and 13 ‘confidence in managing symptoms’,
which have the response options in the reverse order).
Scores are summed, ranging from 0 to 56, where 56 is
the best possible state of musculoskeletal health. The
relatively brief format makes the MSK-HQ more suitable
to monitor and compare musculoskeletal health status
across various conditions and throughout the clinical
pathway. The original version of the MSK-HQ has dem-
onstrated high completion rates, good test-retest reliabil-
ity and strong convergent validity with reference
standards in four different MSK cohorts [14]. However,
a questionnaire’s usability and measurement properties
cannot necessarily be transferred to other countries, lan-
guages and healthcare systems [15–17]. Therefore, care-
ful translation, cross-cultural adaptation, testing and
validation are necessary in order to take account any
cultural and comprehensibility-related differences be-
tween the countries. Although, cross-cultural adaptation
and within country evaluation often are performed with
PROMs, assessment of measurement invariance with re-
spect to language and patients characteristics, as well as
direct comparison of measurement properties across
countries are less frequent. The objectives of the present
study were to 1) translate and cross-cultural adapt the
MSK-HQ for use in a Danish-speaking population, and
2) evaluate and compare measurement properties of the
MSK-HQ across Danish (DK) and English (UK) cohorts
of patients consulting primary care physiotherapy ser-
vices with musculoskeletal pain.
Methods
Translation and cross-cultural adaptation
We translated the MSK-HQ into Danish in accord-
ance with international standards [18] . This was
done in close collaboration with the license holder of
the MSK-HQ questionnaire, Oxford University
Innovation Ltd. (http://innovation.ox.ac.uk) and a rep-
resentative of the research group, who developed the
questionnaire (JCH). A professional English language
translator specialising in medical translation and a bi-
lingual physiotherapist, both Danish native speakers,
translated the questionnaire from English into Danish.
Subsequently, their translations were compared at a
consensus meeting in the project group with partici-
pation of both translators. A professional native
English-speaking translator back-translated the ques-
tionnaire from Danish into English, without any prior
knowledge of the original version. The back-
translation was compared to the original version.
Afterwards, the translation report was reviewed by
JCH and approved. Finally, we performed cognitive
debriefing interviews with 13 patients with musculo-
skeletal disorders recruited in one physiotherapy clinic
in the Central Denmark Region. The results of the
cognitive debriefing were presented and reviewed in
the project group and the final version of the ques-
tionnaire was completed.
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Design and study populations
The study was a prospective comparative study encom-
passing two consecutively recruited cohorts of patients
with musculoskeletal disorders in primary physiotherapy
practice in DK and UK.
DK cohort
Participants
Consecutive adult (≥18 years) consulters referred to
physiotherapy with a musculoskeletal disorder were
invited to participate in six physiotherapy (PT) clinics
in the Central Denmark Region. Participants had to
be able to understand and speak Danish well enough
to complete questionnaires, with no further inclusion
criteria applied. In the period January–July 2017 a
total of 180 patients agreed to participate, of whom
27 were excluded due to ‘no show’/cancelations (n =
9), withdrawal (n = 5), other diagnosis than musculo-
skeletal (n = 2), other reasons (n = 4) or did not
complete baseline questionnaire (n = 7), leaving 153
patients for analysis.
Data collection
At first contact, the patient was informed about the
project. If the patient agreed to participate, an e-mail
with a link to an electronic questionnaire was sent to
the patient (baseline). The questionnaire included the
Danish versions of the MSK-HQ, the generic EQ-5D-
5L [19–21] and validated reference standard measures
depending on the pain region from which the pa-
tient’s main problem originated; Shortened Disabilities
of the Arm, Shoulder and Hand (Q-DASH) [22, 23],
Neck and Back disability Indexes (ODI and NDI)
[24–26], Pain, stiffness and function modules of Knee
injury and Hip Disability Osteoarthritis Outcome
Scores (KOOS and HOOS) [27–29]. An appointment
was made for a first PT consultation (test-retest) 5–7
days later. Immediately before this appointment, the
patient once more completed the questionnaire.
Follow-up questionnaires were sent after six and 12
weeks by e-mail. In addition, in retest and follow-up
questionnaires, patients were asked to rate the overall
change in their condition on a 7-point scale (much
better, better, slightly better, unchanged, slightly
worse, worse, much worse). A total of 134 patients
(88%) completed the test-retest questionnaire (median
time interval 6 days [Inter quartile range 3–8 days]).
Follow-up questionnaires were completed by 118 pa-
tients (77%) at 6 weeks and 128 patients (84%) at 12
weeks. For comparison with the UK cohort only the




The UK cohort was drawn from the primary care
physiotherapy sample used as the original validation co-
hort for the MSK-HQ. The details of materials and
methods have previously been described elsewhere [14].
Briefly, the cohort included 210 consecutive consulters
in community musculoskeletal physiotherapy clinics in
five UK West-Midlands towns. Of those 166 (78%) with
test-retest data were available for the present study.
Data collection
Participants completed the English paper version of the
MSK-HQ and the EQ-5D-5L index before the start of
treatment at the first clinic visit (baseline) and again at
the second visit, typically 2 weeks later (test–retest).
Follow-up questionnaires were completed at 12 weeks by
133 (80%) patients. A transition question on overall
change in the condition on a 5-point scale (much better,
slightly better, unchanged, slightly worse, much worse)




Descriptive statistics were calculated for all variables and
compared between the two cohorts. Sum scores were
calculated at all time points and raw scores were calcu-
lated if no more than 3 items were missing in the re-
spective score; otherwise, the score was left missing.
Possible floor and ceiling effects were examined and
such effects were considered to be present if more than
15% of the respondents achieved the highest or the low-
est sum score, respectively.
Construct validity
As no reference standard measures were collected for
the UK primary care cohort [14], we only assessed con-
struct convergent validity for the Danish version of the
MSK-HQ. This was done by correlation analyses be-
tween the MSK-HQ scores and the relevant reference
standard measures scores at baseline (Q-DASH, ODI,
NDI and WOMAC scores calculated from KOOS and
HOOS). Likewise longitudinal convergent validity was
assessed by correlation analyses between MSK-HQ and
reference standard measures change scores at 12 weeks.
Based on findings from the original validation study of
the MSK-HQ [14] and previous literature of health out-
come research [30–32], we expected correlations be-
tween MSK-HQ and relevant reference standard
measures to be at moderate to strong (r = ≥ 0.5).
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Cross-cultural validity and measurement invariance
Measurement invariance according to language, categor-
ies of age, pain site, duration of pain, and work status,
was assessed by Differential item functioning (DIF) ana-
lysis of baseline ratings of the two cohorts. DIF is the as-
sessment of the extent to which items function
differently between various groups, when the scores
among those groups are corrected for. Uniform dichot-
omous DIF on the raw scores was assessed in this paper
via the Mantel-Haenszel (MH) statistic calculated in the
R 3.4.1 [33] package difR [34]. Item purification was
used and adjustment for multiple comparisons was made
via Holm’s method. The assessment of the effect size for
the DIF was made on the ETS Delta scale for the dichot-
omous categories (i.e., country, duration, work status)
[35]. Note that MSK-HQ items were dichotomised such
that the two lower impact categories (‘not at all’ and
‘slightly/rarely’) opposed the three higher impact cat-
egories. Furthermore, for the assessment of pain loca-
tion, ‘neck’ was collapsed with ‘back’ as there were too
few instances of neck pain to calculate the MH statistic
robustly.
Measurement error and reliability
As test-retest was administered differently in the two co-
horts with respect to time interval and initiation of treat-
ment, we restricted the analysis to patients who reported
their condition to be ‘stable’ between administrations.
Systematic measurement error between MSK-HQ scores
at baseline and retest was analysed by Bland-Altman plot
and paired t-test for the DK and UK cohorts. Further
random errors were estimated by standard error of
measurement (SEM) and minimal detectable change
(MDC =1.96 × √2 × SEM) was calculated. Cronbach’s
alpha was calculated to assess internal consistency. The
intra class correlation coefficient (ICC 2.1) was used to
assess test-retest reliability, and for single items Cohen’s
Kappa with quadratic weights was used. Confidence in-
tervals (95% CI) for Kappa values were obtained using
non-parametric bootstrap methods (1000 replications).
Sensitivity to change, responsiveness and interpretability
To evaluate sensitivity to change MSK-HQ change scores
from baseline to 12 weeks and effect-size statistics (i.e.,
mean change/ standard deviation at baseline) were calcu-
lated and compared between the two cohorts. For respon-
siveness the MSK-HQ’s ability to discriminate between
unchanged patients was calculated and compared between
cohorts by receiver-operating-characteristic (ROC) curve
analyses with large improvement (much better, better ver-
sus a little better, unchanged, little worse) and small im-
provement (much better, better, little better versus
unchanged), using the transition question as external an-
chor. Responsiveness to worsening was not analysed, as
only few patients rated their condition to be ‘worse’ or
‘much worse’. Minimal clinically important change (MCIC)
values were estimated by the Pythagoras’ Theorem (a^2 +
b^2 = c^2) to choose the change score closest to the upper
left-hand corner, which best discriminated between im-
proved and unchanged patients [36]. As MCIC values can
be affected by baseline scores, analysis was repeated with
relative change scores (i.e., change scores expressed as per-
centages of the baseline scores) [37]. Finally, as a key vison
for the development of the MSK-HQ was to produce a sin-
gle musculoskeletal health measure superior to generic
health tools, we compared effect size estimates and areas
under the ROC curve for the MSK-HQ and the EQ-5D
change scores [38]. The statistical package STATA version
15 was used.
Results
Translation and cross- cultural adaptation
In the translation process a few items had to be slightly
rephrased and the response category ‘severely’ was chan-
ged to ‘a lot’ to fit the Danish language. A few other is-
sues were raised during translation. The two different
constructs; pain and stiffness used in item 1 and item 2
led to some discussion in the project group, as well as
the different constructs in item 12 ‘understanding condi-
tion’ and item 13 ‘confidence in managing’. However,
cognitive debriefing interviews with pilot patients (five
males and eight females, 32–59 years of age) with vari-
ous musculoskeletal disorders revealed no difficulties
with respect to the above-mentioned concerns. In gen-
eral, patients found the Danish version of the MSK-HQ
easy to complete (2–6 min) and items were well under-
stood, thus no further changes were needed. Patients did
not seem to distinguish between pain and stiffness, and
most patients found the items regarding understanding
their condition (item 12) and confidence in managing
(item 13) to be important. The Danish version of the
MSK-HQ is available on licence request: https://process.
innovation.ox.ac.uk/clinical.
Descriptive statistics
The patient characteristics of both cohorts are presented
in Table 1. The two cohorts were fairly similar with re-
spect to distribution of pain sites. The patients in the
DK cohort were slightly younger, included more women,
and had a higher percentage of patients who were work-
ing. No floor or ceiling effects were observed at any time
point. In the Danish cohort missing data was replaced
by mean item scores for two patients who left two items
unanswered and two patients who left three items un-
answered at baseline, and two patients who left one item
at retest and follow-up. For the UK cohort mean item
score was calculated for two patients leaving one item
unanswered.
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Construct validity
The correlation coefficients (Spearman Rho) between
the Danish MSK-HQ and relevant reference standard
measures were 0.63 (CI, 0.38 to 0.79) for the Q-DASH,
0.71 (CI, 0.53 to 0.88) for the ODI, 0.60 (CI, 0.25 to
0.81) for the NDI, and for the WOMAC 0.84 (CI, 0.73
to 0.91). Corresponding values for change scores were
0.65 (CI, 0.38 to 0.82) for the Q-DASH, 0.74 (CI, 0.54 to
0.86) for the ODI, 0.52 (CI, 0.05 to 0.80) for the NDI,
and for the WOMAC 0.70 (CI, 0.50 to 0.83).
Cross cultural validity and measurement invariance
With regards to country differences, three items showed
statistically significant levels of DIF, all with large effect
sizes1 according to the ETS Delta scale [35], these were
items 2 (pain/stiffness at night; lower than expected in
UK – MH= 8.54, p = 0.04), 12 (understanding condition;
lower than expected in DK - MH =11.37, p = 0.01), and
13 (confidence in managing; lower than expected in DK
- MH = 15.21, p = 0.001). With regards to pain location,
three items showed statistically significant levels of DIF,
items 3, 4 and 5. Item 3 (walking; hardest for lower ex-
tremities, moderate for back/neck and easiest for upper
extremities - MH = 38.71, adj.p < 0.001), item 4 (wash-
ing/dressing; harder for upper extremities, easier for
lower extremities and back/neck - MH = 11.34, adj. p =
0.04), item 5 (physical activity levels; easier for upper
extremities, harder for lower extremities and back/neck
- MH = 14.57, adj.p = 0.01). With regards to age group,
pain duration and working status, no items exhibited
statistically significant DIF.
Measurement error and reliability
Of 134 patients in the DK cohort and 165 patients in
the UK cohort with retest MSK-HQ data available, 98
Table 1 Patient characteristics
Variables DK cohort (n = 153) UK cohort (n = 166)
Pain site
Back 45 (29.4) 47 (28.3)
Neck 23 (15.0) 7 (4.2)
Upper extremity 38 (24.8) 35 (21.1)
Lower extremity 47 (30.7) 57 (34.3)
Other/unknown – – 20 (12.0)
Gender
Woman 97 (63.4) 92 (55.4)
Men 56 (36.6) 74 (45.6)
Age
Years mean, (SD) 50.4 (13.8) 53.7 (15.7)
Work status
Working 96 (62.8) 94 (56.6)
Not working/Subsided job 6 (3.9) 7 (4.2)
Not working/unemployed 14 (9.2) 5 (3.0)
Retired 26 (17.0) 52 (31.1)
On sick leave 11 (7.2) 7 (4.2)
Unknown – – 1 (0.1)
Duration of symptoms
≤ 3 months 62 (40.5) 77 (47.2)
> 3 months 91 (59.4) 66 (39.8)
Unknown – – 23 (13.9)
Baseline score
MSK-HQ (0 to 56) mean, (SD) 32.3 (9.2) 30.5 (9.6)
EQ-5D-5L index (−0.6 to 1.0) mean, (SD) 0.69 (0.16) 0.55 (0.25)
Values are numbers (percentages) unless stated otherwise
Abbreviations: SD standard deviation
1Note: the ETS Delta Scale has three categorisations for DIF; (A)
Negligible: non-significant or effect size lower than 1, (B) Intermediate:
neither A nor C true, (C) Large: Effect size > 1.5 AND significantly dif-
ferent from an effect size of 1. See the reference for the calculation of
the effect size.
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and 82 patients reported their condition to be ‘stable’
between baseline and retest, respectively and were
thus used to calculate the reliability statistics pre-
sented in Table 2. When compared to the UK cohort,
smaller systematic and random errors were observed
in the Danish cohort and ICC values were slightly
higher. Internal consistency was high for both co-
horts. The median (range) weighted kappa with
squared weights across the 14 items for the DK co-
hort was 0.69 (0.54 to 0.84) as compared to 0.67
(0.31 to 0.80) in the UK cohort. Details of the test-
retest reliability of single items of the MSK-HQ are
available in Appendix A.
Sensitivity to change, responsiveness and interpretability
At 12 weeks for the DK cohort mean change scores
were 9.1 (95% CI, 7.7 to 10.6); ES 1.1 (CI 0.9 to 1.2)
for the MSK-HQ and mean EQ-5D-5L index scores
were 0.08 (CI, 0.06 to 0.10); ES 0.7 (CI, 0.5 to 0.8).
The corresponding values for the UK cohort were
mean score 8.9 (CI, 7.4 to 10.5); ES 0.9 (CI, 0.8 to
1.1) for the MSK-HQ and for the EQ-5D-5L index
mean score 0.11 (CI, 0.07 to 0.14); ES 0.5 (CI 0.3 to
0.6). The correlations (Spearman Rho) between the
transition question of change in main complaint and
MSK-HQ change scores were − 0.66 (CI, − 0.75 to −
0.55) and − 0.54 (CI, − 0.65 to − 0.40) for the DK and
UK cohorts, respectively. Table 3 presents the ROC
analyses and MCIC estimates according to the two
cut points of patient perceived important change in
main complaint. Although, ROC AUC differed be-
tween the DK and UK cohorts, these differences did
not reach statistical significance. The MCIC estimate
for absolute change at 12 weeks was larger for the DK
cohort, whereas for the percentages of change the op-
posite was true. The percentages reaching the MCIC
threshold for ‘large improvement’ were 48% in the
DK cohort and 47% in the UK-cohort, whereas the
corresponding values for ‘small improvements’ were
57 and 56%, respectively. Figure 1 illustrates the ROC
curves representing change scores for the MSK-HQ
as compared to EQ-5D-5L index at 12 weeks. For
both cohorts the MSK-HQ produced higher ROC
AUCs than the EQ-5D-5L. For the DK cohort the dif-
ference between MSK-HQ and EQ-5D-5L ROC areas
index reached borderline statistical significance for
both large improvement (p = 0.05) and small improve-
ment (p = 0.06).
Discussion
This is the first study to evaluate and compare meas-
urement properties of the new MSK-HQ tool across
different international cohorts of musculoskeletal pa-
tients consulting primary care physiotherapy services.
The MSK-HQ was translated and cross-cultural
adapted to Danish speaking population. The Danish
version of the MSK-HQ demonstrated good face val-
idity and construct validity was confirmed by moder-
ate to strong correlations with relevant reference
standard measures. In the DIF analysis three items
displayed measurement non-invariance for language
(pain/stiffness at night, understanding condition, con-
fidence in managing) and three for pain location
(walking, washing/dressing, physical activity levels),
whereas no differences were observed for age, pain
duration and working status. For both cohorts the
MSK-HQ demonstrated good internal consistency, ac-
ceptable levels of reliability and responsiveness with
reliability coefficients and ROC estimates exceeding
0.70 [15].
The study benefitted from prospectively collected
data in two comparable physiotherapy cohorts with
high completion rates on questionnaires. The study
had some limitations. No formal sample size calcula-
tion for the present study was performed, but as
both cohorts exceeded the COSMIN recommenda-
tions of at least 100 individuals for quantitative
PROM studies [15], we believe the sample sizes of
the two cohorts to be adequate. It should also be
noted that data of the two cohorts was collected and
administrated differently. Thus, only limited popula-
tion descriptors across the two cohorts were avail-
able, with data being less complete in the
comparative UK cohort for the variables pain site
and duration of symptoms. The questionnaires in the
UK cohort were paper based whereas questionnaires
in the DK cohort were completed online. As studies
comparing paper Vs, online administered patient-
reported outcome measures indicate these two as-
sessment methods are highly comparable [39], it is
unlikely to have affected our results.
The high completion rate, acceptable face and con-
struct validity observed confirmed earlier promising
findings from the initial validation study [14]. In
Table 2 Measurement error and reliability of MSK-HQ scores for
the DK cohort and the UK cohort
DK-cohort (n = 98) UK- cohort (n = 82)
Measurement error
Mean Difference (95% CI) 1.6 (0.7 to 2.5) 3.9 (2.7 to 5.1)
SEM (95% CI) 3.1 (2.7 to 3.6) 3.6 (3.1 to 4.1)
MDC (95% CI) 8.6 (7.6 to 10.1) 9.9 (8.7 to 11.3)
Reliability
ICC (95% CI) 0.86 (0.81 to 0.91) 0.80 (0.50 to 0.90)
Cronbach’s α (Baseline) 0.88 (0.85 to 0.91) 0.89 (0.86 to 0.89)
Abbreviations: CI Confidence interval, SEM Standard error of the measurement,
MDC Minimal Detectable Change;
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Table 3 ROC and MCIC estimates according to patient perceived important change in main complaint
Cut points n (%) ROCAUC (95% CI) MCICROC Sensitivity/ specificity % MCICpercent
Large improvement
DK cohort 64 (52.5) 0.83 (0.75 to 0.90) 10 78/81 26
UK cohort 49 (37.1) 0.79 (0.71 to 0.87) 8 78/69 29
Small improvement
DK cohort 87 (74.3) 0.85 (0.77 to 0.92) 8 76/80 26
UK cohort 85 (64.9) 0.76 (0.68 to 0.85) 6 71/71 29
a) Large improvement (much better, better versus a little better, unchanged, little worse)
b) Small improvements (much better, better, little better versus unchanged)
MCICROC: Estimated as the optimal cut-off point of the ROC curve using absolute change scores
MCICpercent: Estimated as the optimal cut-off point of the ROC curve using relative change scores
Abbreviations: ROC receiver operating characteristic, AUC area under the curve, CI confidence interval
Fig. 1 Receiver-operating-characteristic (ROC) curves representing absolute change scores of the MSK-HQ and EQ-5D-5L. Values are ROC area
estimates (95% confidence intervals)
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terms of reliability and measurements error the DK
version seems to perform slightly better than the UK
version in our study. We also observed a significantly
larger systematic measurement error of test-retest
scores of MSK-HQ for the UK cohort. These findings
may, in part, be explained by differences in study de-
signs. The DK cohort patients completed test-retest
questionnaires with a 6 days interval before any treat-
ment was initiated, whereas patients in the UK cohort
completed it within a 2 weeks interval. Although,
these differences were levelled out by restricting test-
retest analysis to ‘stable’ patients only, it is possible
that the longer time interval could have resulted in
more improvement among ‘stable’ patients in the UK-
cohort. It could be argued that restricting analysis to
‘stable’ patients would inevitably produce lower MDC
estimates, than if ‘unstable’ patients were included.
However in our case, if all available patients had been
included it would only have increased the MDC esti-
mate by approximately one point (results not shown),
and therefore not have changed the overall conclusion
of the study. Another limitation of the present study
was that classification of improved or unchanged pa-
tients were based on a single transition scale question
as external anchor (i.e. improvement in overall condi-
tion), which might measure varying aspects of the
outcome [32]. The use of several anchors covering
different aspects of the outcome (e.g. pain, function
and patient satisfaction) might have produced other
results. Furthermore, note that alternative methods to
derive MCIC estimates do exist [40, 41] however we
chose to use the ROC curve method to preserve com-
parability with other studies in the field and commu-
nicability with readers unfamiliar with alternative
methods.
Three MSK-HQ items exhibited DIF across coun-
tries. Item 2 ‘pain/stiffness’ at night was scored
lower (i.e. more pain/stiffness) in UK patients al-
though no differences were found for the similar
item 1 ‘pain/stiffness’ during the day. DK patients
had lower item scores with regards to understanding
condition and confidence in managing (item 12 and
13). These differences may either imply translational
problems, cultural differences or true differences be-
tween cohorts. This should be further investigated
through qualitative inquiries to explore how patients
understand and interpret these questions across
countries. Although, these two items were deemed
important and relevant by patients, they have previ-
ously shown to correlate poorly with the total MSK-
HQ score [14]. Hence, it could be discussed whether
to include these items in the overall sum score or to
use these questions separately to facilitate patient
communication and shared clinical decision making.
The findings that no MSK-HQ items differed for
age, pain duration and working status adds to the
pervious results from the validation study on the ori-
ginal version [14]. With regards to pain location, the
lower scores found in item 3 ‘walking’ for extrem-
ities and back/neck patients, when compared to
upper extremity patients was not an unexpected
finding, and seems in line with the opposite pattern
for item 4 ‘washing/dressing’. It could be speculated
that the higher scores found for upper extremities
patients for item 5 ‘physical activity levels’, may be
due to examples given (going for a walk or jogging),
as these do not included physical activities related to
upper extremities. Adding riding your bike or play-
ing tennis/golf could be a potential solution to this
discrepancy between pain sites.
The distinction between formative (i.e., the items cause
the construct) and reflective (i.e., the construct causes
that which is measured by the items) tools is not always
easy to make and tools can exhibit aspects of both con-
ceptual frameworks [42]. Note that previously, the MSK-
HQ had been considered to be a formative tool however
on further reflection we feel that tool is much better
characterised as being reflective. The measurement prop-
erty estimates observed for the MSK-HQ in the present
study did not differ from most existing region-specific
PROMs [7, 9, 10, 43] and general musculoskeletal
PROMs [44]. For PROMs, reliability coefficients ≥0.7 are
considered adequate for group comparisons, whereas
≥0.9 are needed to monitor individual patients [45].
Similar to most musculoskeletal PROMs, the MSK-HQ
only exceed the first mentioned threshold, and therefore,
at present, may be most suitable for group evaluation.
MDC values for musculoskeletal PROMs are commonly
reported to range from 10 to 20% of the scale, which is
in line with our findings for the MSK-HQ. To ensure
that a change score on an individual patient level is clin-
ically relevant, the MCIC should be greater than, or at
least equal to, the random measurement error (MDC) of
an instrument. This was only true in the Danish cohort
of the present study and for the cut-off-level of large im-
provements, making the interpretability of small changes
of individual scores of the MSK-HQ more challenging.
As MCIC estimates based on relative scores were un-
affected by the cut-off level of the transition question
and relative scores have shown to be less sensitive to
baseline scores [37]; the MCICpercent seems the prefera-
ble choice. However, both absolute and relative MCIC
values varied between the two cohorts. These differences
may partly be rooted in the use of different scaling of
transition question of main complaint (DK cohort 7 ver-
sus 5 response categories), where a stronger correlation
between the transition question and MSK-HQ change
scores at 12 weeks was observed. On the other hand the
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proportion exceeding MCIC thresholds between the DK
cohort and UK cohort did not differ substantially; large
improvements (48% versus 47%) and small improve-
ments (57% versus 55%). The MSK-HQ seems to dis-
criminate well between unchanged and improved
patients across the two cohorts. A key vision of the
MSK-HQ was to produce a single broad health-status
measure more sensitive to change than generic health
tools. In both cohorts effect sizes of the MSK-HQ were
considerably larger than those of the EQ-5D-5L, which
indicates superiority of the MSK-HQ. Whereas for the
ability of MSK-HQ to discriminate between improved
and unchanged (i.e. responsiveness) a patient at 12
weeks, superiority was only observed with respect to the
Danish cohort.
Conclusions
In this study we performed a cross-country com-
parison of the MSK-HQ questionnaire among mus-
culoskeletal patients consulting primary care
physiotherapy services. Although, some discrepancy
for language and pain site location was found for
single items, the MSK-HQ generally produced
comparable results across the two cohorts. The Da-
nish version of the MSK-HQ appears to outper-
form the original English version and has shown to
be a reliable, valid, sensitive and responsive instru-
ment to capture and monitor musculoskeletal
health status.
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